Galectins and gliomas

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 17-27

  Le Mercier, Marie ^a   Fortin, Shannon ^a   Mathieu, Véronique ^a   Kiss, Robert ^a   Lefranc, Florence ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Galectin; Glioma; Migration; Resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; GALECTIN; GALECTIN 1; GALECTIN 3; GALECTIN 8; INTEGRIN; SMALL INTERFERING RNA; TEMOZOLOMIDE;

APOPTOSIS; CANCER INVASION; CANCER PATIENT; CANCER RESISTANCE; CANCER SURVIVAL; CELL DEATH; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DRUG POTENTIATION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; MELANOMA B16; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SURVIVAL TIME; TUMOR; TUMOR VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL HYPOXIA; CELL MOVEMENT; GALECTINS; GLIOMA; HUMANS; INTEGRINS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 71549114583     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00270.x     Document Type: Review

References (134)

1. Aplin AE, Howe AK, Juliano RL (1999) Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11 : 737 744.
2. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T et al (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76 : 597 598.
3. Barondes SH, Cooper DN, Gitt MA, Leffler H (1994) Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269 : 20807 20810.
4. Bartik P, Maglott A, Entlicher G, Vestweber D, Takeda K, Martin S, Dontenwill M (2008) Detection of a hypersialylated beta1 integrin endogenously expressed in the human astrocytoma cell line A172. Int J Oncol 32 : 1021 1031.
5. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36 : 1046 1069.
6. Belot N, Rorive S, Doyen I, Lefranc F, Bruyneel E, Dedecker R et al (2001) Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 36 : 375 390.
7. Boraldi F, Annovi G, Carraro F, Naldini A, Tiozzo R, Sommer P, Quaglino D (2007) Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochim Biophys Acta 1774 : 1402 1413.
8. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85 : 1301 1307.
9. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80 : 776 787.
10. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H et al (2001) Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 11 : 12 26.
11. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H et al (2002) Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61 : 585 596.
12. Camby I, Decaestecker C, Lefranc F, Kaltner H, Gabius HJ, Kiss R (2005) Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochem Biophys Res Commun 335 : 27 35.
13. Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16 : 137R 157R.
14. Carcamo C, Pardo E, Oyanadel C, Bravo-Zehnder M, Bull P, Caceres M et al (2006) Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp Cell Res 312 : 374 386.
15. Chintala SK, Tonn JC, Rao JS (1999) Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 17 : 495 502.
16. Claes A, Idema AJ, Wesseling P (2007) Diffuse glioma growth: a guerilla war. Acta Neuropathol 114 : 443 458.
17. Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V. (1999) Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3 : 317 325.
18. D'Abaco GM, Kaye AH (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14 : 1041 1048.
19. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572 : 285 293.
20. Debray C, Vereecken P, Belot N, Teillard P, Brion JP, Pandolfo M, Pochet R (2004) Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun 325 : 1393 1398.
21. Decaestecker C, Debeir O, Van Ham P, Kiss R (2007) Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration. Med Res Rev 27 : 149 176.
22. Deininger MH, Trautmann K, Meyermann R, Schluesener HJ (2002) Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. Anticancer Res 22 : 1585 1592.
23. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C, Salmon I (2008) The galectin family and digestive disease. J Pathol 215 : 1 12.
24. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA (2007) Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64 : 1679 1700.
25. Eto K, Puzon-McLaughlin W, Sheppard D, Sehara-Fujisawa A, Zhang XP, Takada Y (2000) RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem 275 : 34922 34930.
26. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, Andre S et al (2005) Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280 : 37266 37277.
27. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15 : 297 310.
28. Fortin S, Le Mercier M, Camby I, Spiegl-Kreinecker S, Berger W, Lefranc F, Kiss R (2008) Galectin-1 is implicated in the protein Kinase C epsilon/Vimentin-controlled trafficking of integrin-beta1 in Glioblastoma cells. Brain Pathol In Press.
29. Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T et al (2006) Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res 66 : 3114 3119.
30. Fukumori T, Kanayama HO, Raz A (2007) The role of galectin-3 in cancer drug resistance. Drug Resist Updat 10 : 101 108.
31. Fukushi J, Makagiansar IT, Stallcup WB (2004) NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 15 : 3580 3590.
32. Gagner JP, Law M, Fischer I, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: imaging and experimental therapeutics. Brain Pathol 15 : 342 363.
33. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21 : 1624 1636.
34. Gladson CL (1999) The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58 : 1029 1040.
35. Goetz JG, Joshi B, Lajoie P, Strugnell SS, Scudamore T, Kojic LD, Nabi IR (2008) Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 180 : 1261 1275.
36. Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M et al (1999) Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Appl Neurobiol 25 : 319 330.
37. Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA et al (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206 : 291 304.
38. Gu M, Wang W, Song WK, Cooper DN, Kaufman SJ (1994) Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. J Cell Sci 107 : 175 181.
39. Gunnersen JM, Spirkoska V, Smith PE, Danks RA, Tan SS (2000) Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32 : 146 154.
40. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y (2000) Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113 : 2385 2397.
41. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100 : 57 70.
42. He J, Baum LG (2006) Galectin interactions with extracellular matrix and effects on cellular function. Methods Enzymol 417 : 247 256.
43. Hernandez JD, Baum LG (2002) Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 12 : 127R 136R.
44. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T et al (2004) Galectin-9 in physiological and pathological conditions. Glycoconj J 19 : 593 600.
45. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I et al (2003) Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103 : 370 379.
46. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS et al (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7 : 7 16.
47. Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99 : 1583 1593.
48. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2 : 91 100.
49. Houzelstein D, Goncalves IR, Fadden AJ, Sidhu SS, Cooper DN, Drickamer K et al (2004) Phylogenetic analysis of the vertebrate galectin family. Mol Biol E 21 : 1177 1187.
50. Hu R, Jin H, Zhou S, Yang P, Li X (2007) Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 28 : 399 407.
51. Hughes RC (1999) Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473 : 172 185.
52. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110 : 673 687.
53. Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R (2006) Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem 13 : 3513 3527.
54. Ingrassia L, Nshimyumukiza P, Dewelle J, Lefranc F, Wlodarczak L, Thomas S et al (2006) A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma. J Med Chem 49 : 1800 1807.
55. Jensen RL (2006) Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus 20 : E24.
56. Johnson KD, Glinskii OV, Mossine VV, Turk JR, Mawhinney TP, Anthony DC et al (2007) Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia 9 : 662 670.
57. Jung TY, Jung S, Ryu HH, Jeong YI, Jin YH, Jin SG et al (2008) Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. J Neurosurg 109 : 273 284.
58. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7 : 134 153.
59. Kim HR, Lin HM, Biliran H, Raz A (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 59 : 4148 4154.
60. Koumenis C (2006) ER stress, hypoxia tolerance and tumor progression. Curr Mol Med 6 : 55 69.
61. Kuklinski S, Pesheva P, Heimann C, Urschel S, Gloor S, Graeber S et al (2000) Expression pattern of galectin-3 in neural tumor cell lines. J Neurosci Res 60 : 45 57.
62. Lahm H, Andre S, Hoeflich A, Fischer JR, Sordat B, Kaltner H et al (2001) Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127 : 375 386.
63. Lakka SS, Gondi CS, Rao JS (2005) Proteases and glioma angiogenesis. Brain Pathol 15 : 327 341.
64. Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G et al (2008) Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol Appl Pharmacol 229 : 172 183.
65. Le Mercier M, Mathieu V, Haibe-Kains B, Bontempi G, Mijatovic T, Decaestecker C et al (2008) Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol 67 : 456 469.
66. Le Mercier M, Fortin S, Mathieu V, Roland I, Spiegl-Kreinecker S, Haibe-Kains B et al (2009) Galectin-1 pro-angiogenic and pro-migratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia In Press.
67. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY et al (2005) Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 : 8932 8941.
68. Le QT, Kong C, Lavori PW, O'Byrne K, Erler JT, Huang X et al (2007) Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 69 : 167 175.
69. Leffler H (2001) Galectins structure and function - a synopsis. Results Probl Cell Differ 33 : 57 83.
70. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2004) Introduction to galectins. Glycoconj J 19 : 433 440.
71. Lefranc F, Brotchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23 : 2411 2422.
72. Lefranc F, James S, Camby I, Gaussin JF, Darro F, Brotchi J et al (2005) Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts. J Neurosurg 102 : 706 714.
73. Lefranc F, Sadeghi N, Camby I, Metens T, Dewitte O, Kiss R (2006) Present and potential future issues in glioblastoma treatment. Expert Rev Anticancer Ther 6 : 719 732.
74. Lefranc F, Facchini V, Kiss R (2007) Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12 : 1395 1403.
75. Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5 : 29 41.
76. Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1 : 97 117.
77. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer (IARC) : Lyon.
78. Maglott A, Bartik P, Cosgun S, Klotz P, Ronde P, Fuhrmann G et al (2006) The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells. Cancer Res 66 : 6002 6007.
79. Mann MJ, Hendershot LM (2006) UPR activation alters chemosensitivity of tumor cells. Cancer Biol Ther 5 : 736 740.
80. Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I et al (2007) Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 127 : 2399 2410.
81. McClung HM, Thomas SL, Osenkowski P, Toth M, Menon P, Raz A et al (2007) SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. Neurosci Lett 419 : 172 177.
82. Megalizzi V, Mathieu V, Mijatovic T, Gailly P, Debeir O, De Neve N et al (2007) 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia 9 : 358 369.
83. Moiseeva EP, Spring EL, Baron JH, de Bono DP (1999) Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix. J Vasc Res 36 : 47 58.
84. Moiseeva EP, Javed Q, Spring EL, de Bono DP (2000) Galectin 1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res 45 : 493 502.
85. Moiseeva EP, Williams B, Goodall AH, Samani NJ (2003) Galectin-1 interacts with beta-1 subunit of integrin. Biochem Biophys Res Commun 310 : 1010 1016.
86. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H et al (2002) Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 50 : 392 401.
87. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME (2007) Molecular targets of glioma invasion. Cell Mol Life Sci 64 : 458 478.
88. Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10 : 267 275.
89. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156 : 899 909.
90. Natarajan M, Hecker TP, Gladson CL (2003) FAK signaling in anaplastic astrocytoma and glioblastoma tumors. Cancer J 9 : 126 133.
91. Neder L, Marie SK, Carlotti CG, Jr., Gabbai, AA, Rosemberg S, Malheiros SM et al (2004) Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Brain Pathol 14 : 399 405.
92. Nickel W (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270 : 2109 2119.
93. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochem 33 : 14109 14114.
94. Ochieng J, Leite-Browning ML, Warfield P (1998) Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 246 : 788 791.
95. Paulus W, Baur I, Beutler AS, Reeves SA (1996) Diffuse brain invasion of glioma cells requires beta 1 integrins. Lab Invest 75 : 819 826.
96. Perillo NL, Pace KE, Seilhamer JJ, Baum LG (1995) Apoptosis of T cells mediated by galectin-1. Nature 378 : 736 739.
97. Perillo NL, Marcus ME, Baum LG (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76 : 402 412.
98. Primakoff P, Myles DG (2000) The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16 : 83 87.
99. Puchades M, Nilsson CL, Emmett MR, Aldape KD, Ji Y, Lang FF et al (2007) Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. J Proteome Res 6 : 869 875.
100. Rabinovich GA (2005) Galectin-1 as a potential cancer target. Br J Cancer 92 : 1188 1192.
101. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23 : 313 320.
102. Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, Kier-Joffe EB, Fainboim L (2002) Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ 9 : 661 670.
103. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3 : 489 501.
104. Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) " Pseudopalisading" necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65 : 529 539.
105. Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S et al (2001) Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 33 : 241 255.
106. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A et al (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 5 : 241 251.
107. Rutka JT (1986) The K.G. McKenzie award lecture - 1986. Effects of extracellular matrix proteins on the growth and differentiation of an anaplastic glioma cell line. Can J Neurol Sci 13 : 301 306.
108. Rutka JT, Myatt CA, Giblin JR, Davis RL, Rosenblum ML (1987) Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis. Can J Neurol Sci 14 : 25 30.
109. Rutka JT, Apodaca G, Stern R, Rosenblum M (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69 : 155 170.
110. Rutka JT, Muller M, Hubbard SL, Forsdike J, Dirks PB, Jung S et al (1999) Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression. J Neuropathol Exp Neurol 58 : 198 209.
111. Saal I, Nagy N, Lensch M, Lohr M, Manning JC, Decaestecker C et al (2005) Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol Histopathol 20 : 1191 1208.
112. Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, Rabinovich GA (2008) Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opin Biol Ther 8 : 45 57.
113. Salgaller ML, Liau LM (2006) Current status of clinical trials for glioblastoma. Rev Recent Clin Trials 1 : 265 281.
114. Saussez S, Kiss R (2006) Galectin-7. Cell Mol Life Sci 63 : 686 697.
115. Saussez S, Camby I, Toubeau G, Kiss R (2007) Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 29 : 874 884.
116. Seelenmeyer C, Wegehingel S, Tews I, Kunzler M, Aebi M, Nickel W (2005) Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol 171 : 373 381.
117. Singhal S, Wiewrodt R, Malden LD, Amin KM, Matzie K, Friedberg J et al (2003) Gene expression profiling of malignant mesothelioma. Clin Cancer Res 9 : 3080 3097.
118. Stillman BN, Mischel PS, Baum LG (2005) New roles for galectins in brain tumors-from prognostic markers to therapeutic targets. Brain Pathol 15 : 124 132.
119. Strik HM, Deininger MH, Frank B, Schluesener HJ, Meyermann R (2001) Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas. J Neurooncol 53 : 13 20.
120. Strik HM, Schmidt K, Lingor P, Tonges L, Kugler W, Nitsche M et al (2007) Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration. Oncol Rep 18 : 483 488.
121. Tews DS (2000) Adhesive and invasive features in gliomas. Pathol Res Pract 196 : 701 711.
122. Tews DS, Nissen A (1998) Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors. Invasion Metastasis 18 : 271 284.
123. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103 : 15975 15980.
124. Thijssen VL, Poirier F, Baum LG, Griffioen AW (2007) Galectins in the tumor endothelium; opportunities for combined cancer therapy. Blood 110 : 2819 2827.
125. Thijssen VL, Hulsmans S, Griffioen AW (2008) The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 172 : 545 553.
126. Tredan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99 : 1441 1454.
127. Uhm JH, Gladson CL, Rao JS (1999) The role of integrins in the malignant phenotype of gliomas. Front Biosci 4 : D188 99.
128. Vladimirova V, Waha A, Luckerath K, Pesheva P, Probstmeier R (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res 86 : 2450 2461.
129. Wang D, Anderson JC, Gladson CL (2005) The role of the extracellular matrix in angiogenesis in malignant glioma tumors. Brain Pathol 15 : 318 326.
130. Wen Y, Makagiansar IT, Fukushi J, Liu FT, Fukuda MN, Stallcup WB (2006) Molecular basis of interaction between NG2 proteoglycan and galectin-3. J Cell Biochem 98 : 115 127.
131. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T (2000) Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 59 : 722 730.
132. Zeng Y, Danielson KG, Albert TJ, Shapiro IM, Risbud MV (2007) HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc. J Bone Miner Res 22 : 1851 1861.
133. Zhou J, Schmid T, Schnitzer S, Brune B (2006) Tumor hypoxia and cancer progression. Cancer Lett 237 : 10 21.
134. Zick Y, Eisenstein M, Goren RA, Hadari YR, Levy Y, Ronen D (2004) Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J 19 : 517 526.